---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-078294"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T05:02:06.690241+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics CFO resigns; appoints Alexander Epshinsky; boosts ATM capacity to $50M

## Summary
- Joan Brown resigned as CFO effective Sept 12, 2024; no disagreement with company.
- Alexander Epshinsky appointed CFO effective Sept 12; $340k base salary, $50k signing bonus, $160k RSUs (3-year vest).
- ATM sales agreement second amendment increases placement shares capacity to $50 million.
- Company states it paused financing but now, with new CFO, will pursue financing opportunities.

## SEC filing metadata
- accession: 0001213900-24-078294
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/0001213900-24-078294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/ea0214462-8k_allarity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-078294
- JSON: https://secwatch.observer/filing/0001213900-24-078294.json
- Plain text: https://secwatch.observer/filing/0001213900-24-078294.txt

## Key facts
- Executive change
  Joan Y. Brown resigned as Chief Financial Officer at Allarity Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On September 12, 2024, the Company received a notice of resignation from Joan Y. Brown, its Chief Financial Officer, effective September 12, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/0001213900-24-078294-index.htm
- Executive change
  Alexander Epshinsky was appointed as Chief Financial Officer at Allarity Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 12, 2024, the Board of Directors (the “Board”) of the Company approved the appointment of Alexander Epshinsky as the Chief Financial Officer of the Company as of September 12, 2024, succeeding Ms. Brown.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/0001213900-24-078294-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.